New Jersey-based pharmaceutical product manufacturer Glenmark Generics Inc. USA has agreed to pay Texas $11.25 million to resolve an enforcement action levied against the company by the Lone Star State.
The agreement resolves an investigation under the Texas Medicaid Fraud Prevention Act against Glenmark for allegedly fraudulently reporting inflated drug prices to the state’s Medicaid program.
Because the Medicaid program is jointly funded by Texas and U.S. taxpayers, the federal government is…Miyerkules, Abril 8, 2015
Texas to recover millions from New Jersey drug company
New Jersey-based pharmaceutical product manufacturer Glenmark Generics Inc. USA has agreed to pay Texas $11.25 million to resolve an enforcement action levied against the company by the Lone Star State.
The agreement resolves an investigation under the Texas Medicaid Fraud Prevention Act against Glenmark for allegedly fraudulently reporting inflated drug prices to the state’s Medicaid program.
Because the Medicaid program is jointly funded by Texas and U.S. taxpayers, the federal government is…
Mag-subscribe sa:
I-post ang Mga Komento (Atom)
Walang komento:
Mag-post ng isang Komento